Pharma IQ Members

Industry Reports & Infographics

Pharma is devoted to providing pharma professionals with the most comprehensive selection of case studies, reports and infographics on the internet. Get in-depth information through Pharma IQ's pharma and biotechnology industry reports. Our materials aim to educate industry leaders as they make complex business decisions that drive growth, innovation and ROI. 

365 whitepaper results
of 36

Pharma IQ revisits the compound and biobanking markets to pinpoint any shifts or new trends in the market.Learn more


We spoke to CRISPR experts Robin Ketteler and Lorena Benedetti to find out about their work within CRISPR, insights on where the technique is heading and the field’s exciting developments.Learn more

CRISPR Content

CRISPR is now one of the most affordable forms of gene editing causing a boom in R&D over the last few years. However, the technique does have its limitations which include maintaining end to end control on genetic manipulation, avoiding off targets effects and pathway recovery post double strand break.Ahead of the 2017 CRISPR summit Javier Terriente, CSO, ZeClinics and Danilo Maddalo Lab Head ONC Pharmacology,... Learn more

disposables regulation

Unsurprisingly, it can be a challenge for the industry to keep pace with all of these entities and the best practices that they are putting forward. In response to this, Pharma IQ has created this snapshot guide to a election of bodies active within the single-use-systems market to provide insight into their achievements over the past year and potential updates to keep an eye out for.Learn more

Veeva, email, life sciences, communication, PR, marketing, business development, market access, doctor, corporate, veeva

Many life sciences companies are guilty of overlooking the impact of impersonal one-size-fits all email campaigns.Learn more

Single use systems, Disposable solutions, pharma, manufacturing, biomanufacturing, GMP, Good manufacturing processes, stainless steel,

Single use systems in biomanufacturing can greatly simplify the path to market. This is due to the reduction of sterilisation time and spend, lowered labor efforts, swifter set up times, lower cross contamination levels and reduced operating costs in the production of pharma products. As a result, many are implementing more single use systems within their production lines. Pharma IQ interviewed its network to pinpoint the specific trends in the industry and forecasts made by market players.Learn more

Software design, medical devices, med devices, software for medical devices, medical software, apps

The Medical Device Technologies Market is forecasted to undergo exponential growth from 2015 up to 2021. Forecasted global market value for emerging medical device technologies by 2021: £90.8bn This is from 2016’s valuation of $55.9 billionLearn more

cyber security, cyber attack, cyber. medical devices, software for medical devices, healthcare, patients, hacker, hack, malicious software, protection, cyber protection

The world of healthcare has greatly benefitted from enhanced connectivity as a by-product of the digital age. However, this benefit has contributed to exposing medical devices and their softwares to cyber attacks. Malicious digital interferences can be significantly detrimental to patient safety.Ahead of the 2017 Software for Medical Devices conference, Pharma IQ brings you this whitepaper looking at what you need to know in regards to software cyber security to medical devices.Learn more


According to a recent study, the global single use technology biopharmaceutical market reached $1.7 billion in 2014, a $0.3 billion jump from the year prior. Looking at the period of 2014 – 2019, the market is predicted to expand at a compound annual growth rate of 11.7 per cent to almost $3 billion. (4)The US market is expected to increase to $1.1 billion by 2019 from 2014’s $573 million. However, Europe is expected to grow at a slightly slower pace, from $599m in 2014 to $... Learn more


The war against counterfeit pharmaceuticals in the supply chain is well underway, with more than 40 markets – those of which including the EU, US, South Korea, Brazil and China, deploying pharmaceutical track and trace laws. According to industry specialist Tracelink, by the end of 2018 more than 75% of the globe’s prescription medications are expected to be protected by legislation.Learn more

365 whitepaper results
of 36